Penpulimab, CAS 2350298-92-7

Product Description: Penpulimab is an IgG1 backbone anti-PD-1 monoclonal antibody with antitumor activities[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Huang Z, et al. Penpulimab, an Fc-Engineered IgG1 Anti-PD-1 Antibody, With Improved Efficacy and Low Incidence of Immune-Related Adverse Events. Front Immunol. 2022 Jun 27;13:924542./[2]Yunlong Shan, et al. Anlotinib enhanced penpulimab efficacy through remodeling of tumor vascular architecture and immune microenvironment in hPD-L1/hPD-1 humanized mouse model. Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021) 2581-2581.

CAS Number: 2350298-92-7

Molecular Weight: N/A

Compound Purity: 98.80

Research Area: Cancer; Inflammation/Immunology

Solubility: H2O

Target: PD-1/PD-L1

• Artikelnummer: MEXHY-P99108-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99108-5
• Green Labware: Nein
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK